Announced Wed, 12 Aug · 14:46 IST
Shukra Pharma Q1 FY26 results: Revenue jumps over 4x YoY
Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+11.5%1-day move
₹37.00
prior close
₹40.05
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6-0.1-0.6-0.6+11.5—————————
Up moveDown movePending
AI summary
Shukra Pharmaceuticals reported Q1 FY26 standalone revenue of Rs 2,352.23 lakhs, up about 336% from Rs 539.11 lakhs in Q1 FY25. Net profit surged to Rs 1,502.98 lakhs from Rs 102.96 lakhs, with EPS of Rs 0.34. Total expenses dropped sharply to Rs 381.97 lakhs from Rs 512.78 lakhs. Consolidated net profit stood at Rs 1,295.85 lakhs on similar revenue. No investor complaints pending.
Likely market impact
Massive YoY revenue and profit growth signals strong momentum. Likely positive for stock sentiment.